Zoll's Propaq M monitor cleared by FDA
This article was originally published in Clinica
Executive Summary
Propaq M, a vital signs monitor developed by Zoll Medical, has received 510(k) clearance from the US FDA. The product, which is designed for use by the military, is a companion monitor to the firm's Propaq MD military monitor/defibrillator, which was cleared in August (www.clinica.co.uk, 2 August 2010). Both devices operate in the same way, which allows users to switch between them easily and reduces training expenses, Zoll says. In addition, many existing Propaq and Zoll accessories currently in military use will be compatible with the new products. Propaq M is nearly 2.3kg lighter than current monitors, Chelmsford, Massachusetts-based Zoll claims. It includes new features such as 12-lead monitoring and a night vision goggle mode.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.